Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Smitz, J.
Right arrow Articles by Hu, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smitz, J.
Right arrow Articles by Hu, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol 13, 664-669, Copyright © 1998 by Oxford University Press


ARTICLES

Epidermal growth factor combined with recombinant human chorionic gonadotrophin improves meiotic progression in mouse follicle-enclosed oocyte culture

J Smitz, R Cortvrindt and Y Hu
Centre for Reproductive Medicine, University Hospital and Medical School, Dutch-speaking Brussels Free University, Belgium.

Using a mouse early preantral follicle culture system, mature full grown oocytes, arrested in prophase I of meiosis, were produced after 12 days using a recombinant gonadotrophin-supplemented medium. This culture medium does not mimic the normal extracellular environment of the oocyte and might therefore modify meiotic regulation and more particularly progression to metaphase II (MII). The aim of this study was to optimize the treatment using recombinant stimulatory ligands which were known to induce germinal vesicle breakdown (GVBD) and completion of meiosis I, metaphase II (MII), namely recombinant follicle stimulating hormone (r-FSH), chorionic gonadotrophin (r-HCG) and epidermal growth factor (EGF). Full-grown intrafollicular oocytes could not resume meiosis when the 'ovulatory' stimulus was r-FSH, used at a 100 times higher dose than during culture. r-FSH did not increase progesterone production. When 1.5 IU/ml r-HCG was used as meiotic trigger, germinal vesicle breakdown was obtained in 95% of the oocytes 64% of which extruded a first polar body. r-HCG induced a dramatic increase in progesterone production. When EGF was administered as sole stimulus on day 12 to the attached follicle-enclosed oocytes, only doses > or =5 ng/ml could cause GVBD, although less effectively than r- HCG (45 versus 95%; P < 0.0001). Oocytes undergoing GVBD by the EGF pulse reached metaphase II at a rate of 54% (not significant versus r- HCG). EGF did not stimulate progesterone production. Addition of increasing doses of EGF (0.5; 5; 10; 50 ng/ml) to r-HCG did not increase the GVBD-rate, but EGF doses >5 ng/ml improved MI to MII transition (P=0.027), thereby improving the final yield of MII oocytes by 12.5%. These data show that up to a dose of 50 ng/ml, EGF on its own could only override the somatic inhibitory stimuli in less than half of the cultured follicles. However, in addition to HCG, EGF (25 ng/ml) had a stimulatory effect on completing the first meiotic division. It was concluded that, under the present culture conditions, EGF in combination with HCG provided optimal nuclear maturation.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ReproductionHome page
S. Romero and J. Smitz
Epiregulin can effectively mature isolated cumulus-oocyte complexes, but fails as a substitute for the hCG/epidermal growth factor stimulus on cultured follicles
Reproduction, June 1, 2009; 137(6): 997 - 1005.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T. Adriaenssens, C. Mazoyer, I. Segers, S. Wathlet, and J. Smitz
Differences in Collagen Expression in Cumulus Cells after Exposure to Highly Purified Menotropin or Recombinant Follicle-Stimulating Hormone in a Mouse Follicle Culture Model
Biol Reprod, May 1, 2009; 80(5): 1015 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
I. Segers, T. Adriaenssens, W. Coucke, R. Cortvrindt, and J. Smitz
Timing of Nuclear Maturation and Postovulatory Aging in Oocytes of In Vitro-Grown Mouse Follicles with or Without Oil Overlay
Biol Reprod, May 1, 2008; 78(5): 859 - 868.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
D. L. Russell and R. L. Robker
Molecular mechanisms of ovulation: co-ordination through the cumulus complex
Hum. Reprod. Update, May 1, 2007; 13(3): 289 - 312.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Conti, M. Hsieh, J.-Y. Park, and Y.-Q. Su
Role of the Epidermal Growth Factor Network in Ovarian Follicles
Mol. Endocrinol., April 1, 2006; 20(4): 715 - 723.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
D Nogueira, R Cortvrindt, B Everaerdt, and J Smitz
Effects of long-term in vitro exposure to phosphodiesterase type-3 inhibitors on follicle and oocyte development
Reproduction, August 1, 2005; 130(2): 177 - 186.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. Lenie, R. Cortvrindt, T. Adriaenssens, and J. Smitz
A Reproducible Two-Step Culture System for Isolated Primary Mouse Ovarian Follicles as Single Functional Units
Biol Reprod, November 1, 2004; 71(5): 1730 - 1738.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
F. Sun, I. Betzendahl, Y. Shen, R. Cortvrindt, J. Smitz, and U. Eichenlaub-Ritter
Preantral follicle culture as a novel in vitro assay in reproductive toxicology testing in mammalian oocytes
Mutagenesis, January 1, 2004; 19(1): 13 - 25.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
I. Demeestere, A. Delbaere, C. Gervy, M. Van den Bergh, F. Devreker, and Y. Englert
Effect of preantral follicle isolation technique on in-vitro follicular growth, oocyte maturation and embryo development in mice
Hum. Reprod., August 1, 2002; 17(8): 2152 - 2159.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. M. Mitchell, C. R. Kennedy, and G. M. Hartshorne
Effects of varying gonadotrophin dose and timing on antrum formation and ovulation efficiency of mouse follicles in vitro
Hum. Reprod., May 1, 2002; 17(5): 1181 - 1188.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Pang and W. Ge
Epidermal Growth Factor and TGF{alpha} Promote Zebrafish Oocyte Maturation in Vitro: Potential Role of the Ovarian Activin Regulatory System
Endocrinology, January 1, 2002; 143(1): 47 - 54.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Y. Hu, I. Betzendahl, R. Cortvrindt, J. Smitz, and U. Eichenlaub-Ritter
Effects of low O2 and ageing on spindles and chromosomes in mouse oocytes from pre-antral follicle culture
Hum. Reprod., April 1, 2001; 16(4): 737 - 748.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H. Newton and P. Illingworth
In-vitro growth of murine pre-antral follicles after isolation from cryopreserved ovarian tissue
Hum. Reprod., March 1, 2001; 16(3): 423 - 429.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G.L. Driscoll, J.P.P. Tyler, J.T. Hangan, P.R. Fisher, M.A. Birdsall, and D.C. Knight
A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation
Hum. Reprod., June 1, 2000; 15(6): 1305 - 1310.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. De La Fuente, M. J. O'Brien, and J. J. Eppig
Epidermal growth factor enhances preimplantation developmental competence of maturing mouse oocytes
Hum. Reprod., December 1, 1999; 14(12): 3060 - 3068.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.